Product NDC: | 0135-0508 |
Proprietary Name: | NICORETTE |
Non Proprietary Name: | nicotine polacrilex |
Active Ingredient(s): | 2 mg/1 & nbsp; nicotine polacrilex |
Administration Route(s): | ORAL |
Dosage Form(s): | LOZENGE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0135-0508 |
Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA022360 |
Marketing Category: | NDA |
Start Marketing Date: | 20100301 |
Package NDC: | 0135-0508-01 |
Package Description: | 24 LOZENGE in 1 CONTAINER (0135-0508-01) |
NDC Code | 0135-0508-01 |
Proprietary Name | NICORETTE |
Package Description | 24 LOZENGE in 1 CONTAINER (0135-0508-01) |
Product NDC | 0135-0508 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | nicotine polacrilex |
Dosage Form Name | LOZENGE |
Route Name | ORAL |
Start Marketing Date | 20100301 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
Substance Name | NICOTINE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes |